Johnson & Johnson (JNJ) Free cash flow 2016–2025
Johnson & Johnson (JNJ) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$19.7BFY2025 · since FY2016: $15.5B → $19.7B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $19.7B | -0.7% |
| FY2024 | $19.8B | +8.7% |
| FY2023 | $18.2B | +6.2% |
| FY2022 | $17.2B | -13.0% |
| FY2021 | $19.8B | -2.1% |
| FY2020 | $20.2B | +1.4% |
| FY2019 | $19.9B | +7.5% |
| FY2018 | $18.5B | +4.2% |
| FY2017 | $17.8B | +14.4% |
| FY2016 | $15.5B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice